RADx match to diagnostic start-up racing to develop and market aptamer-test for COVID and other diseases
In 2020, NIH released $1.5B to the diagnostic community to rapidly develop diagnositics for COVID 19. CRS was matched to a small, aptamer-developed diagnostic company, one out of thousands that applied, who made it through several funding and development programs. We are thrilled to help them with their trials programs, mobile app development, grant submissions, Quality Manageemnt System (QMS), investor strategy, regulatory strategy and partnership strategy.
